HomeNews

News

  • Breakthrough Gene treatment in Alzheimer’s announced by Scientists

    • April 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New Alzheimer’s definition proposed by Researchers

    • April 15, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Migraine CGRP drugs assessed for Clinical effectiveness & Economic impacts by recent ICER report

    • April 14, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • EMD Serono Highlights Commitment to Advance MS Treatment with Investigational Cladribine Tablets and Rebif® Data at AAN 2018

    • April 14, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Beta-interferon & Glatiramer acetate pose low infection risks to MS patients, study reinforces

    • April 13, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Eisai to distribute Biogen’s MS drugs in India

    • April 12, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Mylan acquires rights for new MS drug

    • April 11, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • CRLs, leading to fremanezumab launch delay in Migraine, acknowledged by Celltrion

    • April 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Mavenclad (cladribine) approved for Active RMS in UAE

    • April 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Mother to fly to Mexico for Stem cell MS treatment

    • April 9, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more